Patents by Inventor Stanley Chang
Stanley Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230207128Abstract: Introduced here is an approach for managing errors generated during artificial intelligence-based analysis encrypted data. As an illustrative example, a computing system can may be configured to generate, train, and/or implement machine learning (ML) models to detect or predict aspects of one or more types of cancer based on homomorphically encrypted patient health data. The computing system may selectively identify timing for implementing a noise management mechanism during the data processing for the ML models.Type: ApplicationFiled: December 28, 2022Publication date: June 29, 2023Inventors: Stanley Chang, Wendy Kewen Wang
-
Patent number: 10842804Abstract: Muparfostat for use in reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion, is disclosed. The hepatocellular carcinoma patient with microvascular invasion is identified by examining a resected liver tumor sample from the HCC patient for the presence of microvascular invasion in the sample.Type: GrantFiled: February 8, 2018Date of Patent: November 24, 2020Assignee: Medigen Biotechnology CorporationInventors: Stanley Chang, Kuan-Lang Lai
-
Patent number: 10313788Abstract: An example apparatus for detecting loudspeaker faults includes a switch detector to detect that a loudspeaker fault detection switch is enabled. The apparatus also includes an audio receiver to receive an echo energy threshold and audio from a microphone in a test area. The apparatus further includes an audio analyzer to detect that the echo energy threshold is not exceeded by an acoustic echo in the captured audio. The apparatus includes a fault generator to generate a loudspeaker fault in response to detecting the acoustic echo does not exceed the echo energy threshold.Type: GrantFiled: October 19, 2017Date of Patent: June 4, 2019Assignee: Intel CorporationInventors: Stanley Chang, Alan Yao
-
Publication number: 20190124443Abstract: An example apparatus for detecting loudspeaker faults includes a switch detector to detect that a loudspeaker fault detection switch is enabled. The apparatus also includes an audio receiver to receive an echo energy threshold and audio from a microphone in a test area. The apparatus further includes an audio analyzer to detect that the echo energy threshold is not exceeded by an acoustic echo in the captured audio. The apparatus includes a fault generator to generate a loudspeaker fault in response to detecting the acoustic echo does not exceed the echo energy threshold.Type: ApplicationFiled: October 19, 2017Publication date: April 25, 2019Applicant: INTEL CORPORATIONInventors: Stanley Chang, Alan Yao
-
Publication number: 20180250317Abstract: Muparfostat for use in reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion, is disclosed. The hepatocellular carcinoma patient with microvascular invasion is identified by examining a resected liver tumor sample from the HCC patient for the presence of microvascular invasion in the sample.Type: ApplicationFiled: February 8, 2018Publication date: September 6, 2018Inventors: Stanley Chang, Kuan-Lang Lai
-
Publication number: 20180215775Abstract: The present application provides a pharmaceutical composition for use in inhibiting recurrence, aggravation or metastasis of liver cancer, in which the pharmaceutical composition comprises at least one compound having a structure of formula (I) and a pharmaceutically acceptable vehicle.Type: ApplicationFiled: March 15, 2018Publication date: August 2, 2018Inventors: Stanley CHANG, Kuan-Lang Lai
-
Patent number: 9922800Abstract: Embodiments of a method for generating ions in an ion source are provided. The method for generating ions in an ion source includes introducing a dopant gas and a diluent gas into an ion source arc chamber. The method for generating ions in an ion source further includes generating plasma in the ion source arc chamber based on the dopant gas and the diluent gas. In addition, the dopant gas includes carbon monoxide, and the diluent gas includes xenon and hydrogen.Type: GrantFiled: January 17, 2014Date of Patent: March 20, 2018Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTDInventors: Ming-Hui Li, Stanley Chang, Po-Yi Tseng, Chia-Cheng Liu, Chang-Chun Wu, Shen-Han Lin, Chih-Wen Huang, Ming-Hsien Wu
-
Publication number: 20150206690Abstract: Embodiments of a method for generating ions in an ion source are provided. The method for generating ions in an ion source includes introducing a dopant gas and a diluent gas into an ion source arc chamber. The method for generating ions in an ion source further includes generating plasma in the ion source arc chamber based on the dopant gas and the diluent gas.Type: ApplicationFiled: January 17, 2014Publication date: July 23, 2015Applicant: Taiwan Semiconductor Manufacturing Co., Ltd.Inventors: Ming-Hui LI, Stanley CHANG, Po-Yi TSENG, Chia-Cheng LIU, Chang-Chun WU, Shen-Han LIN, Chih-Wen HUANG, Ming-Hsien WU
-
Publication number: 20140135282Abstract: The present application provides a pharmaceutical composition for use in inhibiting recurrence, aggravation or metastasis of liver cancer, in which the pharmaceutical composition comprises at least one compound having a structure of formula (I) and a pharmaceutically acceptable vehicle.Type: ApplicationFiled: June 9, 2011Publication date: May 15, 2014Applicant: MEDIGEN BIOTECHNOLOGY CORPInventors: Stanley Chang, Kuan-Lang Lai
-
Patent number: 7980058Abstract: The present invention relates to an air compression type engine for aviation. The conventional aircraft engine is complicated in structure, consumes expensive aero fuel, and produces extremely loud noise during operation. Therefore, the present invention employs a turbo-charged air compressor to generate high temperature and high pressure gas in the pressure chamber, and uses the reaction thrust force generated by ejecting the compressed air through the nozzle to make the aircraft vertically take off/land, suspend in the air and fly forwardly. Benefited from the simple structure, the manufacture cost of the aircraft engine can be dramatically decreased. Vertically raising and landing the aircraft can be achieved by changing the ejection directed of the compressed air in the pressure chamber. The commonly used gasoline or diesel, which is cost saving and capable of combusting with a high combustion value, can be used instead of the expensive aviation kerosene. Further, the generated noise is quite small.Type: GrantFiled: April 19, 2006Date of Patent: July 19, 2011Inventor: Stanley Chang
-
Publication number: 20100331858Abstract: Systems, devices, and methods for robot-assisted microsurgical stenting are described herein. In some embodiments a tele-robotic microsurgical system for eye surgery include: a tele-robotic master and a slave hybrid-robot; wherein the tele-robotic master has at least one master slave interface controlled by a medical professional; wherein the slave hybrid-robot has at least one robotic arm attached to a frame releasably attached to a patient's head; wherein the at least one robotic arm has a parallel robot and a serial robot; and wherein the serial robot includes a stenting unit which includes a support tube, a pre-bent tube mounted within the support tube and a guide wire extending from the support tube for carrying a stent and for piercing a blood vessel.Type: ApplicationFiled: January 30, 2009Publication date: December 30, 2010Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Nabil Simaan, Howard Fine, Wei Wei, Stanley Chang
-
Publication number: 20100010504Abstract: Systems, devices, and methods for surgery on a hollow anatomically suspended organ are described herein. In some embodiments a tele-robotic microsurgical system for eye surgery include: a tele-robotic master and a slave hybrid-robot; wherein the tele-robotic master has at least two master slave interfaces controlled by a medical professional; wherein the slave hybrid-robot has at least two robotic arms attached to a frame releasably attached to a patient's head; wherein the at least two robotic arms each have a parallel robot and a serial robot; and wherein the serial robot includes a tube housing a cannula.Type: ApplicationFiled: September 19, 2007Publication date: January 14, 2010Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Nabil Simaan, Wei Wei, Roger Goldman, Howard Fine, Stanley Chang
-
Patent number: 7507532Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.Type: GrantFiled: March 7, 2005Date of Patent: March 24, 2009Assignee: Medigen Biotechnology CorporationInventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li, Chih-Ping Hsu, Pei-Hsun Ho
-
Publication number: 20080127629Abstract: The present invention relates to an air compression type engine for aviation. The conventional aircraft engine is complicated in structure, consumes expensive aero fuel, and produces extremely loud noise during operation. Therefore, the present invention employs a turbo-charged air compressor to generate high temperature and high pressure gas in the pressure chamber, and uses the reaction thrust force generated by ejecting the compressed air through the nozzle to make the aircraft vertically take off/land, suspend in the air and fly forwardly. Benefited from the simple structure, the manufacture cost of the aircraft engine can be dramatically decreased. Vertically raising and landing the aircraft can be achieved by changing the ejection directed of the compressed air in the pressure chamber. The commonly used gasoline or diesel, which is cost saving and capable of combusting with a high combustion value, can be used instead of the expensive aviation kerosene. Further, the generated noise is quite small.Type: ApplicationFiled: April 19, 2006Publication date: June 5, 2008Inventor: Stanley Chang
-
Publication number: 20070219162Abstract: The present invention provides a single high-purity liquid comprising a partially fluorinated ether liquid for use as a long-term tamponade agent. Compositions are directed to liquid tamponade agents consisting essentially of DFPE, or to agents comprising a soluble mixture of a partially fluorinated ether and either a silicone liquid (or oil) or a perfluorocarbon liquid (or any other liquid or oil that is clear, colorless, inert and has a low specific gravity). Partially fluorinated ethers that have a specific gravity between 1.1 and 1.5 are well suited to rectify the deficiencies of silicone and perfluorocarbon liquids when they are used as tamponade agents. The soluble mixtures of the invention can be designed to have a specific gravity so that they do not have buoyancy problems (density greater than water), yet having a specific gravity that is not so high as to damage the posterior retina from mechanical forces (specific gravity less than 1.6).Type: ApplicationFiled: November 29, 2006Publication date: September 20, 2007Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Janet Sparrow, Stanley Chang, Roderic Simpson
-
Publication number: 20070207554Abstract: The present invention discloses a device or system, and the method thereof, for determining gastrointestinal parameters with the reference database saved equations for calculating the parameters comprising concentration of dietary formula, the gastric residual volume, the amount of dietary formula retained in the stomach, and volume of dietary formula remaining in stomach.Type: ApplicationFiled: April 13, 2007Publication date: September 6, 2007Inventors: Alex Lin, Wei-Kuo Chang, Stanley Chang
-
Publication number: 20060068411Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.Type: ApplicationFiled: March 7, 2005Publication date: March 30, 2006Applicant: Medigen Biotechnology CorporationInventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li, Chih-Ping Hsu, Pei-Hsun Ho
-
Publication number: 20060063972Abstract: A locking mechanism for an endoscopic overtube comprising a tubular member having a slot extending from the distal end to the proximal end of the tubular member for placement of an endoscope into the lumen configured to slidably receive the endoscope. The slot is cut through a thickened portion that forms a ridge having a plurality of generally transverse or angular holes on opposite sides of the slot. In one embodiment, the overtube is loaded onto the endoscope and then the slot is securely closed by threading an elongated member, such as a string or string-like member, through the holes and pulling the elongated member taut. In another embodiment, the overtube is pre-threaded with the elongated member forming a plurality of loops configured to go over the endoscope and components attached thereto. Once the endoscope is loaded, the elongated member is pulled taut to securely close the slot.Type: ApplicationFiled: September 21, 2004Publication date: March 23, 2006Inventor: Stanley Chang
-
Publication number: 20050153352Abstract: MG20 (CCNDBP1) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MG20 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MG20 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MG20 expression or activity, thereby treating cancer, in vivo.Type: ApplicationFiled: January 7, 2005Publication date: July 14, 2005Inventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li
-
Publication number: 20050131403Abstract: An improved polypectomy snare for removing and retrieving polyps from inside an organ during an endoscopic procedure, such as the colon during a colonoscopy. The improved polypectomy snare has an outer sheath with a tip having a non-planar tip surface shaped and configured so that a cut polyp will better attach to the snare to avoid additional efforts to retrieve the polyp or the loss of the poly. The tip of the outer sheath is configured with one or more spikes having pointed ends to attach to the polyp. In a preferred configuration, the tip has a plurality of spikes extending outwardly from the tip and configured in a generally saw-toothed shape. The spikes can be integral with the outer sheath, directly attached to the outer sheath or part of a cap member that attaches to the sheath.Type: ApplicationFiled: December 13, 2003Publication date: June 16, 2005Inventor: Stanley Chang